Cancer Institute of New Jersey (CINJ), Lung Cancer/Thoracic Program

Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Lung Cancer/Thoracic Program is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

    • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Profiles

    No photo of Joseph Aisner

    Joseph Aisner

    Person

    19742020
    No photo of Jyoti Malhotra

    Jyoti Malhotra

    Person

    20122020

    Projects

    CANCER CENTER SUPPORT GRANT

    Kane, M., Zong, W., Mehnert, J., Manne, S., Delnevo, C., Shen, Z., Ganesan, S., Foran, D., Liu, C., Laskin, D., Shih, W., Aisner, J., Lattime, E., Haffty, B., Bertino, J., August, D., Goodin, S., Goodin, S., August, D., Laskin, D., Shih, W., Rabinowitz, J., Zheng, S., Sant'Angelo, D. B., Tanzer, L. L., Gallo, J., Leibowitz, M., Chin, K. V., Ravikumar, T., Hait, W., Dipaola, R., Libutti, S. K., Kinzy, T. G., Spaulding, H., Amenta, P., Denicola, G., Shen, M. M., Kinzy, T. G., Notterman, D., Amenta, P. S., Rubin, E. H., Cunningham, R. S. & Saunders, T.

    National Institutes of Health

    3/1/97 → 2/29/24

    Project: Research project

    • Participation in the Eastern Cooperative Oncology Group

    Aisner, J.

    National Institutes of Health

    9/2/04 → 4/30/16

    Project: Research project

    • TRIAL OF SURAMIN IN BREAST CANCER

    Aisner, J.

    National Institutes of Health

    9/30/92 → 2/28/94

    Project: Research project

    • Research Output

    A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors

    Stein, M. N., Goodin, S., Gounder, M., Gibbon, D., Moss, R., Portal, D., Lindquist, D., Zhao, Y., Takebe, N., Tan, A., Aisner, J., Lin, H., Ready, N. & Mehnert, J. M., Jun 1 2020, In : Investigational New Drugs. 38, 3, p. 855-865 11 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer (Cancer Chemotherapy and Pharmacology, (2020), 85, 3, (621-626), 10.1007/s00280-020-04037-9)

    Babiker, H. M., Milhem, M., Aisner, J., Edenfield, W., Shepard, D., Savona, M., Iyer, S., Abdelrahim, M., Beach, C. L., Skikne, B., Laille, E., Tsai, K. T. & Ho, T., May 1 2020, In : Cancer chemotherapy and pharmacology. 85, 5, p. 1009-1010 2 p.

    Research output: Contribution to journal › Comment/debate

    Open Access

    • Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer

    Babiker, H. M., Milhem, M., Aisner, J., Edenfield, W., Shepard, D., Savona, M., Iyer, S., Abdelrahim, M., Beach, C. L., Skikne, B., Laille, E., Tsai, K. T. & Ho, T., Mar 1 2020, In : Cancer chemotherapy and pharmacology. 85, 3, p. 621-626 6 p.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations